126 Results for "

chemotherapeutic

" in MedChemExpress (MCE) Product Catalog:
Products (126)

126 Results for "chemotherapeutic" in MCE Product Catalog:

94
94 Publications Verification
Cat. No.: HY-14596
CAS No.: 446-72-0
Purity:  99.82%
Synonyms: NPI 031L
Genistein, a soy isoflavone, is a multiple tyrosine kinases (e.g., EGFR) inhibitor which acts as a chemotherapeutic agent against different types of cancer, mainly by altering apoptosis, the cell cycle, and angiogenesis and inhibiting metastasis.
loading...
    loading...
45
45 Cited Publications
Cat. No.: HY-19543
CAS No.: 14907-98-3
Synonyms: NSC 172924
Brusatol (NSC 172924) is a unique inhibitor of the Nrf2 pathway that sensitizes a broad spectrum of cancer cells to Cisplatin and other chemotherapeutic agents. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Brusatol can be developed into an adjuvant chemotherapeutic agent . Brusatol increases cellular apoptosis .
loading...
    loading...
31
31 Cited Publications
Cat. No.: HY-19824
CAS No.: 18550-98-6
Target:  

Autophagy

Research Areas:  

Cancer

3PO is an inhibitor of PFKFB3. 3PO attenuates the proliferation of several cancer cell lines with IC50s of 1.4-24 μmol/L. 3PO suppresses glucose uptake and decreases the intracellular concentration of Fru-2,6-BP, lactate, ATP, NAD + and NADH. 3PO can be used for the research of cancer .
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-B0245
CAS No.: 55-98-1
Busulfan is a potent alkylating antineoplastic agent. Busulfan causes DNA damage by cross-linking DNAs and DNA and proteins. Busulfan inhibits thioredoxin reductase. Busulfan induces apoptosis. Busulfan is an immunosuppressive and myeloablative chemotherapeutic agent .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-13761
CAS No.: 29767-20-2
Purity:  98.40%
Synonyms: VM26
Target:  

Topoisomerase

Research Areas:  

Cancer

Teniposide is a podophyllotoxin derivative, acts as a topoisomerase II inhibitor, and used as a chemotherapeutic agent.
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-13585
CAS No.: 154-93-8
Purity:  99.91%
Synonyms: BCNU
Research Areas:  

Cancer

Carmustine is an antitumor chemotherapeutic agent, which works by akylating DNA and RNA.
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-10426
CAS No.: 725247-18-7
Purity:  99.67%
Research Areas:  

Cancer

XCT-790 is a potent and selective inverse agonist for ERRα with an IC50 value of 0.37 μM. XCT-790 induces cell death in chemotherapeutic resistant cancer cells. XCT-790 (Compound 12) is inactive against ERRγ and the estrogen receptors ERα and ERβ .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-17419
CAS No.: 3778-73-2
Research Areas:  

Neurological Disease Cancer

Ifosfamide is a CNS-penetrant alkylating chemotherapeutic agent with activity against a wide range of tumors.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-113914
CAS No.: 1034895-42-5
Purity:  99.13%
Synonyms: Elraglusib
Target:  

GSK-3 Apoptosis Autophagy

Research Areas:  

Cancer

9-ING-41 (Elraglusib) is a maleimide-based ATP-competitive and selective glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 of 0.71 μM. 9-ING-41 significantly leads to cell cycle arrest, autophagy and apoptosis in cancer cells. 9-ING-41 has anticancer activity and has the potential for enhancing the antitumor effects of chemotherapeutic agents .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-106634
CAS No.: 459-86-9
Purity:  99.33%
Synonyms: Methylglyoxal-bis(guanylhydrazone); MGBG; Methyl-GAG
Target:  

HIV Apoptosis

Research Areas:  

Infection Cancer

Mitoguazone (Methylglyoxal-bis(guanylhydrazone)) is a synthetic polycarbonyl derivative with potent antineoplastic activity. Mitoguazone is a brain-penetrant and competitive S-adenosyl-methionine decarboxylase (SAMDC) inhibitor that disrupts polyamine biosynthesis. Mitoguazone induces cell apoptosis. Mitoguazone inhibits HIV DNA integration into the cellular DNA in both monocytes and macrophages. Mitoguazone has the potential for acute leukemia, Hodgkin's and non-Hodgkin's lymphoma treatment .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-B1946
CAS No.: 60-51-5
Dimethoate is an organophosphate insecticide and acaricide. Dimethoate is an orally active acetylcholinesterase inhibitor. Dimethoate induces reactive oxygen species (ROS). Dimethoate induces DNA damage and cell apoptosis in vivo. Dimethoate affect immune system in mice .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-130751
CAS No.: 127512-29-2
Purity:  ≥98.0%
Target:  

Liposome

Research Areas:  

Inflammation/Immunology

DODAP is a cationic lipid utilized as the lipid component in liposomes (pKa = 5.59 in TNS binding tests). DODAP is employed for encapsulating siRNA and delivering immunostimulated chemotherapeutic agents both in vitro and in vivo. DODAP holds great promise for research in vaccines and inflammation .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16965
CAS No.: 1609960-30-6
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

TH287 is a potent and selective inhibitor of MTH1, with an IC50 of 0.8 nM. TH287 is highly selective towards MTH1, with no relevant inhibition of MTH2, NUDT5, NUDT12, NUDT14, NUDT16, dCTPase, dUTPase and ITPA at 100 μM. TH287 could act as a chemotherapeutic agent for cancer research .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-150644
CAS No.: 1223194-71-5
Purity:  99.79%
Research Areas:  

Cancer

S07-2010 is a potent pan-AKR1C (aldo-keto reductase family 1 member C) inhibitor, with IC50 values of 0.19, 0.36, 0.47, and 0.73 μM for AKR1C3, AKR1C4, AKR1C1 and AKR1C2, respectively. S07-2010 induces apoptosis in A549/DDP cells. S07-2010 strengthens the cytotoxicity of chemotherapeutic agents in drug-resistant cells. S07-2010 significantly inhibits the proliferation of drug-resistant cells .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-19542
CAS No.: 124753-97-5
Synonyms: C6-Cer; N-Hexanoylsphingosine
Target:  

Apoptosis

Research Areas:  

Cancer

C6 Ceramide (C6-Cer) is a short-chain, cell-permeable ceramide pathway activator with anticancer activity. C6 Ceramide-mediated miR-29b expression participates in the progression of multiple myeloma through suppressing the proliferation, migration and angiogenesis of endothelial cells by targeting Akt signal pathway. C6 Ceramide exhibits multiple anti-cancer properties including cell cycle arrest, Apoptosis, inhibition of tumor growth and enhances the effects of chemotherapy in drug-resistant cancer cells. C6-ceramide can be used as an adjuvant for chemotherapeutic agents, to enhance anti-tumor effects .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-17400
CAS No.: 17902-23-7
Synonyms: FT 207; NSC 148958
Research Areas:  

Cancer

Tegafur (FT 207; NSC 148958) is a chemotherapeutic 5-FU proagent used in the treatment of cancers; is a component of tegafur-uracil.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-17013
CAS No.: 129716-58-1
Synonyms: MS-209 free base
Target:  

P-glycoprotein

Research Areas:  

Cancer

Dofequidar (MS-209 free base) is an orally active quinoline compoundthat blocks P-glycoprotein (P-gp) and multidrug resistance-associated protein-1 (MDR-1). Dofequidar has highly potent reversing effect on multidrug-resistant tumor cells. Dofequidar competitively inhibits ABCB1/P-gp, ABCC1/MRP-1, blocks the efflux of chemotherapeutic agents, increases the drug concentration in cancer cells, and enhances the chemotherapeutic effect .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-17013A
CAS No.: 153653-30-6
Synonyms: MS-209
Target:  

P-glycoprotein

Research Areas:  

Cancer

Dofequidar fumarate (MS-209) is an orally active quinoline compoundthat blocks P-glycoprotein (P-gp) and multidrug resistance-associated protein-1 (MDR-1). Dofequidar fumarate has highly potent reversing effect on multidrug-resistant tumor cells. Dofequidar fumarate competitively inhibits ABCB1/P-gp, ABCC1/MRP-1, blocks the efflux of chemotherapeutic agents, increases the drug concentration in cancer cells, and enhances the chemotherapeutic effect .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B1080A
CAS No.: 27591-97-5
Tilorone is an orally active antiviral agent and interferon inducer that also has potential antineoplastic, immunomodulatory, and metabolic modulating effects. Tilorone induces an abnormally delayed interferon response and primarily stimulates interferon production in lymphoid tissue. Thus, Tilorone exerts antiviral effects and can be used as a chemotherapeutic agent. Tilorone has the potential to inhibit type 2 diabetes by increasing glucose uptake in vivo and in skeletal muscle cells by enhancing Akt2/AS160 signaling and glucose transporter levels .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W014233
CAS No.: 1596-64-1
L-Histidinol dihydrochloride is an orally active histidyl-tRNA synthetase inhibitor. L-Histidinol dihydrochloride interferes with the initiation stage of protein synthesis, thus affecting cell proliferation and metabolism. L-Histidinol dihydrochloride has the effect of modulating the sensitivity of tumor cells to chemotherapeutic agents. L-Histidinol dihydrochloride reduces the toxicity of certain chemotherapeutic agents to normal tissues and enhance the sensitivity of tumor cells to chemotherapeutic agents .
loading...
    loading...